Why Abbott Laboratories Is a Q2 2025 Buy: Growth & Yield

  • If you wonder whether Abbott Laboratories NYSE: ABT is a good buy in Q2 2025, the answer is yes. The company's management, portfolio, cash flow, capital return, and pipeline are why.